A Congiu

989 total citations
25 papers, 531 citations indexed

About

A Congiu is a scholar working on Pathology and Forensic Medicine, Genetics and Hematology. According to data from OpenAlex, A Congiu has authored 25 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 10 papers in Genetics and 10 papers in Hematology. Recurrent topics in A Congiu's work include Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Acute Lymphoblastic Leukemia research (5 papers). A Congiu is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Acute Lymphoblastic Leukemia research (5 papers). A Congiu collaborates with scholars based in Italy, United States and United Kingdom. A Congiu's co-authors include Angelo Michele Carella, Gino Santini, S Nati, P Coser, E Damasio, Patrizio Mazza, L Mangoni, Giovanna Meloni, Giuseppe Visani and Giuseppe Cimino and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

A Congiu

23 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Congiu Italy 12 278 225 224 152 120 25 531
S Nati Italy 14 262 0.9× 216 1.0× 244 1.1× 171 1.1× 75 0.6× 46 542
JJ Spinelli Canada 8 158 0.6× 330 1.5× 184 0.8× 84 0.6× 72 0.6× 12 543
Mathias Haenel Germany 11 301 1.1× 89 0.4× 266 1.2× 131 0.9× 182 1.5× 37 509
C Ghandour France 11 284 1.0× 65 0.3× 189 0.8× 101 0.7× 64 0.5× 17 390
Vittorio Meneghini Italy 12 321 1.2× 107 0.5× 174 0.8× 159 1.0× 139 1.2× 21 516
M Boasson France 12 89 0.3× 303 1.3× 185 0.8× 98 0.6× 36 0.3× 35 547
Frank T. Ward United States 8 161 0.6× 84 0.4× 131 0.6× 197 1.3× 20 0.2× 13 429
JR Schriber United States 8 86 0.3× 365 1.6× 212 0.9× 102 0.7× 62 0.5× 9 528
Emanuela Merla Italy 11 297 1.1× 71 0.3× 143 0.6× 108 0.7× 83 0.7× 17 390
Sabine Bréchignac France 12 77 0.3× 367 1.6× 72 0.3× 274 1.8× 54 0.5× 32 526

Countries citing papers authored by A Congiu

Since Specialization
Citations

This map shows the geographic impact of A Congiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Congiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Congiu more than expected).

Fields of papers citing papers by A Congiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Congiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Congiu. The network helps show where A Congiu may publish in the future.

Co-authorship network of co-authors of A Congiu

This figure shows the co-authorship network connecting the top 25 collaborators of A Congiu. A scholar is included among the top collaborators of A Congiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Congiu. A Congiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carella, Angelo Michele, Elisabetta Todisco, Luca Castagna, et al.. (2008). Reduced-Intensity Conditioning for Allograft (RICT) after Cytoreductive Autograft (ASCT) in Relapsed/Resistant Hodgkin’s Lymphoma (HL). Blood. 112(11). 3294–3294.
2.
4.
Santini, Gino, Teodoro Chisesi, S Nati, et al.. (2004). Fludarabine, Cyclophosphamide and Mitoxantrone for Untreated Follicular Lymphoma: a Report from the Non-Hodgkin's Lymphoma Co-operative Study Group. Leukemia & lymphoma. 45(6). 1141–1147. 7 indexed citations
5.
Santini, Gino, A Congiu, S Nati, et al.. (2002). Autologous stem cell transplantation for aggressive non-Hodgkin's lymphomas. Revista Brasileira de Hematologia e Hemoterapia. 24(2).
7.
Souza, Cármino Antônio De, Gino Santini, Gloria E. Marino, et al.. (2000). Amifostine (WR-2721), a cytoprotective agent during high-dose cyclophosphamide treatment of non-Hodgkin's lymphomas: a phase II study. Brazilian Journal of Medical and Biological Research. 33(7). 791–798. 30 indexed citations
8.
Santini, Gino, S Nati, Mauro Spriano, et al.. (2000). Fludarabine in combination: An effective therapy for relapsed or refractory low-grade non-Hodgkin's lymphoma (LGL): A multicentre experience. 96. 1 indexed citations
9.
Santini, Gino, Cármino Antônio De Souza, A Congiu, et al.. (1999). High-Dose Cyclophosphamide Followed by Autografting Can Improve the Outcome of Relapsed or Resistant Non-Hodgkin's Lymphomas with Involved or Hypoplastic Bone Marrow. Leukemia & lymphoma. 33(3-4). 321–330. 7 indexed citations
10.
Sertoli, M.R., Gino Santini, Teodoro Chisesi, et al.. (1994). MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.. Journal of Clinical Oncology. 12(7). 1366–1374. 31 indexed citations
11.
Carella, Angelo Michele, S Nati, P. Carlier, et al.. (1991). Autologous Unpurged Bone Marrow Transplantation for Acute Non Lymphoblastic Leukemia in First Remission. Leukemia & lymphoma. 5(1). 43–47. 3 indexed citations
12.
Carella, Angelo Michele, A Congiu, P. Carlier, et al.. (1991). Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation in hematological malignancies. Annals of Hematology. 62(5). 156–159. 21 indexed citations
13.
Carella, Angelo Michele, P. Carlier, A Congiu, et al.. (1991). Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin's disease in first complete remission after MOPP/ABVD protocol.. PubMed. 8(2). 99–103. 73 indexed citations
14.
Am, Carella, P. Carlier, A Congiu, et al.. (1991). Nine years' experience with ABMT in 128 patients with Hodgkin's disease: an Italian study group report.. PubMed. 5 Suppl 1. 68–71. 11 indexed citations
15.
Santini, Gino, A Congiu, T. D’Amico, et al.. (1989). Lymphoblastic lymphoma (LBL) and acute lymphoblastic leukaemia (ALL) in adults: relationships and therapeutic perspectives.. PubMed. 4 Suppl 1. 106–7. 2 indexed citations
16.
Carella, Angelo Michele, A Congiu, Patrizio Mazza, et al.. (1988). High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.. Journal of Clinical Oncology. 6(9). 1411–1416. 136 indexed citations
17.
Am, Carella, Gino Santini, S Nati, et al.. (1988). Autologous bone marrow transplantation for acute leukemia in remission. The Genoa experience.. PubMed. 73(2). 119–24. 5 indexed citations
18.
Carella, Angelo Michele, Gino Santini, E Damasio, et al.. (1987). Idarubicin in combination with etoposide and cytarabine in adult untreated acute non lymphoblastic leukemia. European Journal of Cancer and Clinical Oncology. 23(11). 1673–1678. 9 indexed citations
19.
Carella, Angelo Michele, Gino Santini, Armando Santoro, et al.. (1985). Massive chemotherapy with non-frozen autologous bone marrow transplantation in 13 cases of refractory Hodgkin's disease. European Journal of Cancer and Clinical Oncology. 21(5). 607–613. 32 indexed citations
20.
Carella, Angelo Michele, Gino Santini, Domenico Giordano, et al.. (1985). 4-Demethoxydaunorubicin (Idarubicin) in refractory or relapsed acute leukemias. A pilot study. Cancer. 55(7). 1452–1454. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026